HOME >> BIOLOGY >> NEWS
Targeted irradiation: A new weapon against HIV?

Antiretroviral therapy can keep HIV infection in check and delay and ameliorate the symptoms of HIV/AIDS. However, the drugs do not manage to eradicate the virus completely; individuals have to stay on the drugs permanently. Preclinical studies in mice by Ekatarina Dadachova and colleagues (Albert Einstein College of Medicine) published in the international open-access journal PLoS Medicine now suggest a new strategy to locate and kill many if not all HIV-infected cells in the body.

Radioimmunotherapy refers to an approach pioneered by cancer researchers in which patients are injected with antibodies against specific molecules characteristic of cancer cells (or in this case, HIV-infected cells) which carry a radioactive isotope. The approach takes advantage of the antibody's ability to rapidly hone in on its target cells and deliver the radioactive payload which then selectively kills the target cells and any HIV particles within it.

The study included some test-tube experiments on HIV infected human white blood cells as well as experiments on HIV infected mice that were injected with the radioactive antibodies. The researchers found that HIV infected white blood cells were successfully killed by radioactive antibodies that had been developed against specific proteins in the HIV particle that are routinely displayed at the surface of infected cells.

Two different types of antibodies and two different types of radioactive payload were tried. Both antibodies were very effective in targeting HIV infected cells, but one type of radioactive tag (213-Bismuth) was more efficient in killing the HIV-infected target cells than the other (188-Rhenium).

Then, mice were infected with HIV and treated with the radioactive antibodies (these particular mice had a deficient immune system, which means that they can be infected with the HIV virus that normally does not infect mice). The number of HIV infected cells was reduced in the treated m
'"/>

Contact: Andrew Hyde
press@plos.org
44-122-346-3330
Public Library of Science
6-Nov-2006


Page: 1 2

Related biology news :

1. Targeted virus compels cancer cells to eat themselves
2. Targeted drug delivery now possible with pHLIP peptide
3. Targeted therapies showing great promise against colorectal cancer
4. Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates
5. TAT2005 - 3rd International Symposium on Targeted Anticancer Therapies
6. Natures weapon against nerve agents
7. Secondary waste from chemical weapons stockpile disposal
8. Aphids make chemical weapons to fight off killer ladybirds
9. Alien plants attack using resource conservation as weapon, researchers say
10. Replacement warhead program poses challenges for weapons complex
11. UBC researchers find new superbug weapon for near-empty antibiotics arsenal

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... ... August 24, 2020 , ... Elgia ... inflammatory and fibrotic diseases, today announced that Dr. Stacie Canan has joined the ... Dr. Canan previously served as Executive Director of Global Health at Bristol Myers ...
(Date:8/21/2020)... ... 18, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology ... and Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) application ... COVID-19. Approval of this IND allows Sentien to initiate a Phase 1/2 study ...
(Date:8/12/2020)... ... , ... Mosio recently announced its newly updated text message-based ... all sizes. With a focus on tracking symptoms and monitoring outbreaks as well ... helps public health departments automate communications and provide more personalized care and resources ...
Breaking Biology News(10 mins):
(Date:8/15/2020)... ... August 13, 2020 , ... Inc. magazine today revealed that ... ranking of the nation’s fastest-growing private companies. The list represents a unique look ... small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many other well-known names ...
(Date:8/12/2020)... , ... August 11, 2020 ... ... biopharmaceutical cold chain validation engineering firm, is making available for free its ... need to incorporate concurrent transport simulation testing into today’s biologics licensing application ...
(Date:8/7/2020)... Texas (PRWEB) , ... August 06, 2020 , ... ... and DNA vaccine industries, announces it has closed on the purchase of greenfield ... Park in Conroe, TX and includes over 21 acres in the initial acquisition, ...
(Date:8/3/2020)... ... August 03, 2020 , ... Introducing Ardent Animal Health – MediVet ... , Known as MediVet Biologics since its formation in 2016, the ... new Ardent Animal Health will build on its base of innovative therapies for osteoarthritis ...
Breaking Biology Technology:
Cached News: